FOXA2 was expressed only in the endometrial cell line, while FOXA1 was expressed only in the prostate cell line (Figure 1B), in agreement with the tissue expression patterns and that most prostatic adenocarcinomas and LNCaP are of secretory (i.e., luminal) cell origin (36). The gene discussed is FOXA2; the disease is prostate adenocarcinoma.